Login / Signup

Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteraemia (SAFE trial): protocol for a randomised, controlled, open-label, non-inferiority trial comparing 4 and 6 weeks of antibiotic treatment.

David T P BuisC H van WerkhovenM A van AgtmaelH I BaxM BerrevoetsMgj de BoerMjm BontenJ E BosmansJ BrangerS DouiyebLbs GelinckE JongAjj LammersJtm Van der MeerJ J OosterheertE SieswerdaR SoetekouwJ E StalenhoefThomas W van der VaartE A Bij de VaateN J VerkaikMga Van VonderenP J De VriesJ M PrinsKce Sigaloffnull null
Published in: BMJ open (2023)
NL8347 (the Netherlands Trial Register).
Keyphrases
  • study protocol
  • phase iii
  • phase ii
  • open label
  • clinical trial
  • staphylococcus aureus
  • randomized controlled trial
  • pseudomonas aeruginosa
  • combination therapy
  • radiation therapy
  • cystic fibrosis